4.1 Article

Mood and Ambulatory Monitoring of Physical Activity Patterns in Youth with Polycystic Ovary Syndrome

Journal

JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY
Volume 28, Issue 5, Pages 369-372

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jpag.2014.10.010

Keywords

Polycystic ovary syndrome; Physical activity; Obesity; Depression; Ambulatory monitoring

Funding

  1. [1K23HD061598]

Ask authors/readers for more resources

Study Objective: To provide initial insight into physical activity patterns and predictors of moderate to vigorous physical activity (MVPA) in youth with polycystic ovary syndrome (PCOS) by using a multisensor activity monitor. Design: Cross-sectional study analyzing baseline MVPA data using real-time continuous monitoring of physical activity. Body mass index (BMI) and depressive symptoms were examined as predictors of MVPA. Setting: A large, urban children's hospital in the United States. Participants: Thirty-five youth (aged 12 to 21 years) previously diagnosed with PCOS (mean BMI = 38.0 kg/m(2); mean age = 15.4 years, 79% white) who were participants in a behavioral lifestyle intervention. Main Outcome Measures: Total steps, total MVPA, longest continuous bout of MVPA, and frequency of MVPA bouts lasting for 5 to 9 minutes and 10 or more minutes. Results: Sixty percent of youth averaged at least 1 daily MVPA bout lasting 10 or more minutes, and 14% averaged a daily MVPA bout lasting 30 or more minutes. BMI was negatively correlated with MVPA bout duration (P = .04). Parental ratings of depression, but not self-report ratings, were predictive of participants' total MVPA (beta = -.46; P = .01), number of 5- to 9-minute bouts (beta = -.39; P = .03), and bouts of 10 or more minutes (beta = -.35; P = .05). Conclusion: Youth with PCOS may benefit from being prescribed multiple bouts of MVPA lasting less than 30 continuous minutes to meet national recommendations and achieve health benefits. BMI and parental endorsement of child's depression symptoms may be important to consider when assessing and prescribing MVPA to youth with PCOS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available